SEC Says There's 'No Dispute' Biotech Brass Broke Law
The U.S. Securities and Exchange Commission on Friday sought partial judgments against the chief executive officer and chief financial officer of biotechnology company Osiris Therapeutics Inc., telling a Maryland federal judge that...To view the full article, register now.
Already a subscriber? Click here to view full article